Dustin Boothe
Overview
Explore the profile of Dustin Boothe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cruttenden J, Grant J, Evans J, Cannon G, Gaffney D, Poppe M, et al.
Am J Clin Oncol
. 2025 Feb;
PMID: 39901777
Objective: To evaluate whether hypofractionated radiotherapy (HF-RT) in node-negative intact breast cancer significantly increased after guideline updates, trial publications, and COVID-19. Methods: Patients with node-negative breast cancer undergoing lumpectomy and...
2.
Roach E, Weil C, Cannon G, Grant J, Van Meter M, Boothe D
Ann Surg Oncol
. 2024 Apr;
31(7):4527-4539.
PMID: 38647915
Background: For breast cancer with advanced regional lymph node involvement, axillary lymph node dissection (ALND) remains the standard of care for staging and treating the axilla despite the presence of...
3.
Wells S, Boothe D, Ager B, Tao R, Gilcrease 3rd G, Lloyd S
Clin Colorectal Cancer
. 2020 Mar;
19(2):91-99.e1.
PMID: 32173281
Introduction: Using a large national registry, we investigated patterns of care and overall survival (OS) for metastatic rectal cancer patients treated with chemotherapy or radiotherapy (RT), or with a multimodal...
4.
Odei B, Boothe D, Keole S, Vargas C, Foote R, Schild S, et al.
Int J Part Ther
. 2019 Nov;
3(3):398-406.
PMID: 31772989
Purpose: Clinical trials (CTs) in proton beam therapy (PBT) are important for determining its benefits relative to other treatments. An analysis of PBT trials is, thus, warranted to understand the...
5.
Boothe D, Orton A, Kim J, Poppe M, Werner T, Gaffney D
Am J Clin Oncol
. 2019 Oct;
42(11):813-817.
PMID: 31592805
Objectives: In endometrial cancer, the appropriate sequence of adjuvant chemotherapy (aCT) and adjuvant radiation therapy (aRT) is unclear. We aim evaluated whether early chemotherapy is associated with improved overall survival...
6.
Boothe D, Wolfson A, Christensen M, Francis S, Werner T, Gaffney D
Am J Clin Oncol
. 2019 Jun;
42(7):549-554.
PMID: 31169554
Objectives: Lymphovascular space invasion (LVSI) is a known prognostic factor for endometrial carcinomas. However, LVSI as a determinant of treatment benefit has not been fully elucidated. Methods And Materials: Data...
7.
Cannon R, Carpenter P, Boothe D, Buchmann L, Hunt J, Lloyd S, et al.
Otolaryngol Head Neck Surg
. 2018 Apr;
159(3):473-483.
PMID: 29661049
Objectives To investigate clinicopathologic and treatment factors associated with survival in adult head and neck sarcomas in the National Cancer Database (NCDB). To analyze whether treatment settings and therapies received...
8.
Orton A, Boothe D, Evans D, Lloyd S, Monroe M, Jensen R, et al.
Neurosurgery
. 2018 Feb;
83(5):940-947.
PMID: 29481629
Background: The available literature to guide treatment decision making in esthesioneuroblastoma (ENB) is limited. Objective: To define treatment patterns and outcomes in ENB according to treatment modality using a large...
9.
Parashar B, Singh P, Christos P, Arora S, Desai P, Wernicke A, et al.
J Radiosurg SBRT
. 2018 Jan;
2(4):333-338.
PMID: 29296376
Background: To evaluate clinically significant radiotherapy (RT) dose to draining lymph nodes (LN) in patients treated with SBRT. Findings: Early stage non-small cell lung cancer patients treated with SBRT were...
10.
Odei B, Boothe D, Frandsen J, Poppe M, Gaffney D
Clin Lymphoma Myeloma Leuk
. 2017 Oct;
17(12):819-824.
PMID: 29051078
Background: The goal of this study was to assess the survival differences seen in early-stage and advanced-stage nodular lymphocytic predominant Hodgkin lymphoma (NLPHL) based on treatment modality. Patients And Methods:...